Separately, the FDA on Friday informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, that is approved to treat a different type of muscular dystrophy and was ...

With 33% upside to the target price of $300, Morgan Stanley chose Amazon as the team's best bet, based on Amazon Web Services (AWS). They expect the company's cloud computing platform to boost ...